{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:38:38Z","timestamp":1784734718841,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bbmt.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T03:46:16Z","timestamp":1502768776000},"page":"2096-2101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"23","author":[{"given":"Adam","family":"Bryant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeeta","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Huebsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grizel","family":"Anstee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Sabloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Scrivens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Maze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Bredeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Kekre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.08.007_bib0010","author":"Pasquini"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.critrevonc.2013.03.009","article-title":"Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis","volume":"88","author":"Theurich","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0020","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1182\/blood.V126.23.4410.4410","article-title":"Optimizing anti-thymocyte globulin dosing based on recipient absolute lymphocyte count after unrelated allogeneic hematopoietic cell transplant","volume":"126","author":"Kennedy","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0025","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbmt.2014.11.676","article-title":"Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation","volume":"21","author":"Storek","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/bloodadvances.2016001552","article-title":"ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint","volume":"1","author":"Kekre","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0035","first-page":"1355","article-title":"Comparison of the cytotoxicity of 4 preparations of anti-T-cell globulins in various hematological malignancies","volume":"29","author":"Ayuk","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/bmt.2015.148","article-title":"Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation","volume":"50","author":"Binkert","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000446835","article-title":"Impact of ATG dose on the outcome of patients undergoing reduced intensity conditioning followed by allogeneic hematopoietic stem cell transplantation for hematological malignancies","volume":"136","author":"Cornillon","year":"2016","journal-title":"Acta Haematol"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0050","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/cncr.27858","article-title":"Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases","volume":"119","author":"Crocchiolo","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0055","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial","volume":"10","author":"Finke","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0060","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.1111\/ctr.12131","article-title":"A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors","volume":"27","author":"Remberger","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0065","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1182\/blood-2011-01-329821","article-title":"Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius","volume":"117","author":"Socie","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(15)00462-3","article-title":"Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial","volume":"17","author":"Walker","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/bmt.2015.268","article-title":"A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F","volume":"51","author":"Fuji","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0080","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.bbmt.2009.02.010","article-title":"Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia","volume":"15","author":"Kim","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12185-016-1947-9","article-title":"Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation","volume":"103","author":"Kuriyama","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0090","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbmt.2006.12.450","article-title":"Unrelated stem cell transplantation after a reduced intensity conditioning regimen containing high-dose Thymoglobulin leads to controllable graft-versus-host disease","volume":"13","author":"Lacerda","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0095","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood.V128.22.505.505","volume":"128","author":"Soiffer","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3324\/haematol.2016.148510","article-title":"Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"102","author":"Baron","year":"2017","journal-title":"Hematologica"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bmt.2013.107","article-title":"Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice","volume":"49","author":"Ruutu","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0110","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0115","author":"CIBMTR"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kroger","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bmt.1703306","article-title":"Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)","volume":"28","author":"Bacigalupo","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0135","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/bmt.2012.81","article-title":"Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients","volume":"47","author":"Portier","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.08.007_bib0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbmt.2011.08.009","article-title":"Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin","volume":"18","author":"Yu","year":"2012","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117306298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117306298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:38Z","timestamp":1761058778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117306298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1083879117306298"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.08.007","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}